Table of Contents Author Guidelines Submit a Manuscript
Journal of Addiction
Volume 2015, Article ID 507214, 9 pages
http://dx.doi.org/10.1155/2015/507214
Research Article

Risk Factors Associated with Unsafe Injection Practices at the First Injection Episode among Intravenous Drug Users in France: Results from PrimInject, an Internet Survey

1French National Institute of Prevention and Health Education, Scientific Affairs Department, 42 boulevard de la Libération, 93203 Saint-Denis Cedex, France
2Faculty of Nursing, Université Laval, Pavillon Ferdinand-Vandry, Bureau 3465, 1050 avenue de la Médecine, Québec City, QC, Canada G1V 0A6
3French National Institute of Health and Medical Research (INSERM), U1018, Hôpital Paul Brousse, 16 avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France
4Faculty of Medicine and Health Sciences, University of Sherbrooke, Campus de Longueuil, 150 Place Charles-LeMoyne, Bureau 200, Longueuil, QC, Canada J4K 0A8

Received 14 May 2015; Revised 24 August 2015; Accepted 6 September 2015

Academic Editor: Jean-Paul Grund

Copyright © 2015 Anne Guichard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. K. Nelson, B. M. Mathers, B. Cowie et al., “Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews,” The Lancet, vol. 378, no. 9791, pp. 571–583, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. B. M. Mathers, L. Degenhardt, B. Phillips et al., “Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review,” The Lancet, vol. 372, no. 9651, pp. 1733–1745, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Le Vu, Y. Le Strat, F. Barin et al., “Population-based HIV-1 incidence in France, 2003–08: a modelling analysis,” The Lancet Infectious Diseases, vol. 10, no. 10, pp. 682–687, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Jauffret-Roustide, J. Pillonel, L. Weill-Barillet et al., “Estimation of HIV and hepatitis C prevalence among drug users in France—first results from the ANRS-COQUELICOT 2011 survey,” Bulletin Épidémiologie Hebdomadaire, vol. 39-40, pp. 504–509, 2013. View at Google Scholar
  5. E. R. Pouget, H. Hagan, and D. C. Des Jarlais, “Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment,” Addiction, vol. 107, no. 6, pp. 1057–1065, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. EHRN, Young People and Injecting Drug Use in Selected Countries of Central and Eastern Europe, Eurasian Harm Reduction Network, Vilnius, Lithuania, 2009.
  7. E. Wong, Rapid Assessment and Response on HIV/AIDS among Especially Vulnerable Young People in South Eastern Europe, United Nations Children’s Fund, Belgrade, Serbia, 2002.
  8. EMCDDA, Trends in Injecting Drug Use in Europe, EMCDDA, Lisbon, Portugal, 2011.
  9. J. Costes, L. Vaissade, E. Colasante et al., Prévalence de l'Usage Problematique de Drogues en France. Estimations 2006, Observatoire Francais des Drogues et des Toxicomanies, Saint-Denis, France, 2009.
  10. A. Cadet-Taïrou and S. Saïd, “Profils et pratiques des usagers des CAARUD en 2012,” Tendances, vol. 98, pp. 1–8, 2015, http://www.ofdt.fr/publications/collections/periodiques/lettre-tendances/profils-et-pratiques-des-usagers-des-caarud-en-2012-tendances-98-janvier-2015. View at Google Scholar
  11. INSERM, Réduction des Risques Infectieux Chez les Usagers de Drogues, INSERM, Paris, France, 2010.
  12. EMCDDA, “Rapport national 2014 (données 2013) à l'EMCDDA par le point focal français du réseau Reitox. France. Nouveaux développements, tendances,” http://www.ofdt.fr/BDD/publications/docs/efnxofub.pdf.
  13. A. Cadet-Tairou, M. Gandilhon, E. Lahaie et al., Drogues et Usages de Drogues en France. Etat des Lieux et Tendances Récentes 2007–2009, Neuvième Édition du Rapport National du Dispositif TREND, Observatoire Francais des Drogues et des Toxicomanies, Saint-Denis, France, 2010.
  14. A. Cadet-Tairou, M. Gandilhon, A. Toufik, and I. Evard, Phénomènes Émergents liés aux Drogues en 2006. Huitième Rapport National du Dispositif TREND, Observatoire Francais des Drogues et des Toxicomanies, Saint-Denis, France, 2008.
  15. G. Girard and G. Boscher, Pratiques d'Injection en Milieu Festif—État des Lieux en 2008: Données Issues du Dispositif TREND de l'OFDT, Observatoire Francais des Drogues et des Toxicomanies, Saint-Denis, France, 2009.
  16. A. Guichard, F. Lert, C. Calderon et al., “Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France,” Addiction, vol. 98, no. 11, pp. 1585–1597, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Guichard, F. Lert, J. Brodeur, and L. Richard, “Rapports des usagers au Subutex: de la reconquête de l'autonomie à la spirale de l'échec,” Sciences Sociales et Santé, vol. 24, no. 4, pp. 5–43, 2006. View at Publisher · View at Google Scholar
  18. P. Bouhnik, S. Touzé, C. Valette-Viallard, S. le Signe du Matos, and T. Contextes, Risques et Sensations Liés à l'Injection de Produits Psychoactifs, Observatoire Francais des Drogues et des Toxicomanies, Saint-Denis, France, 2002.
  19. H. Hagan, H. Thiede, and D. C. Des Jarlais, “Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion,” Epidemiology, vol. 15, no. 5, pp. 543–549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Maher, B. Jalaludin, K. G. Chant et al., “Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia,” Addiction, vol. 101, no. 10, pp. 1499–1508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Maher, J. Li, B. Jalaludin, K. G. Chant, and J. M. Kaldor, “High hepatitis C incidence in new injecting drug users: a policy failure?” Australian and New Zealand Journal of Public Health, vol. 31, no. 1, pp. 30–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. É. Roy, J.-F. Boudreau, and J.-F. Boivin, “Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience,” Drug and Alcohol Dependence, vol. 102, no. 1–3, pp. 158–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. H. S. B. van den Berg, C. Smit, M. Bakker et al., “Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users,” European Journal of Epidemiology, vol. 22, no. 3, pp. 183–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Bravo, F. Vallejo, G. Barrio et al., “HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection,” International Journal of Drug Policy, vol. 23, no. 5, pp. 415–419, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Baldwin, R. Shrestha, J. Potrepka, and M. Copenhaver, “The age of initiation of drug use and sexual behavior may influence subsequent HIV risk behavior: a systematic review,” ISRN AIDS, vol. 2013, Article ID 976035, 17 pages, 2013. View at Publisher · View at Google Scholar
  26. C. M. Fuller, D. Vlahov, C. A. Latkin, D. C. Ompad, D. D. Celentano, and S. A. Strathdee, “Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users,” Journal of Acquired Immune Deficiency Syndromes, vol. 32, no. 1, pp. 86–93, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. L. A. Goldsamt, A. Harocopos, P. Kobrak, J. J. Jost, and M. C. Clatts, “Circumstances, pedagogy and rationales for injection initiation among new drug injectors,” Journal of Community Health, vol. 35, no. 3, pp. 258–267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. C. Doherty, R. S. Garfein, E. Monterroso, C. Latkin, and D. Vlahov, “Gender differences in the initiation of injection drug use among young adults,” Journal of Urban Health, vol. 77, no. 3, pp. 396–414, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Frajzyngier, A. Neaigus, V. A. Gyarmathy, M. Miller, and S. R. Friedman, “Gender differences in injection risk behaviors at the first injection episode,” Drug and Alcohol Dependence, vol. 89, no. 2-3, pp. 145–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Varescon, G. Vidal-Trecan, B. Gagniere, B. Christoforov, and A. Boissonnas, “Prises de risques lors de la première injection intraveineuse de drogue,” Annales de Médecine Interne, vol. 151, pp. B5–B8, 2000. View at Google Scholar
  31. G. M. Vidal-Trecan, I. Varescon-Pousson, and A. Boissonnas, “Injection risk behaviors at the first and at the most recent injections among drug users,” Drug and Alcohol Dependence, vol. 66, no. 2, pp. 107–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Jauffret-Roustide, L. Oudaya, M. Rondy et al., “Trajectoires de vie et prises de risques chez les femmes usagères de drogues,” Preventive Medecine, vol. 24, no. 2, pp. 111–121, 2008. View at Google Scholar
  33. F. Fernandez, Les Modalités des Prises de Risques Sanitaires Chez les Primo-Injecteurs, Aides/Université de Toulouse Le Mirail, Toulouse, France, 2000.
  34. S. R. White, S. J. Hutchinson, A. Taylor, and S. M. Bird, “Modeling the initiation of others into injection drug use, using data from 2,500 injectors surveyed in Scotland during 2008–2009,” American Journal of Epidemiology, vol. 181, no. 10, pp. 771–780, 2015. View at Publisher · View at Google Scholar
  35. N. Crofts, R. Louie, D. Rosenthal, and D. Jolley, “The first hit: circumstances surrounding initiation into injecting,” Addiction, vol. 91, no. 8, pp. 1187–1196, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. S. E. Hadland, T. Kerr, B. D. L. Marshall et al., “Non-injection drug use patterns and history of injection among street youth,” European Addiction Research, vol. 16, no. 2, pp. 91–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Kerr, M. W. Tyndall, R. Zhang, C. Lai, J. S. G. Montaner, and E. Wood, “Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility,” American Journal of Public Health, vol. 97, no. 7, pp. 1228–1230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. E. Lankenau, K. D. Wagner, J. J. Bloom, B. Sanders, D. Hathazi, and C. Shin, “The first injection event: differences among heroin, methamphetamine, cocaine, and ketamine initiates,” Journal of Drug Issues, vol. 40, no. 2, pp. 241–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. É. Roy, N. Haley, P. Leclerc, L. Cédras, L. Blais, and J.-F. Boivin, “Drug injection among street youths in Montreal: predictors of initiation,” Journal of Urban Health, vol. 80, no. 1, pp. 92–105, 2003. View at Publisher · View at Google Scholar
  40. A. Guichard, R. Guignard, D. Michels et al., “Changing patterns of first injection across key periods of the French Harm Reduction Policy: primInject, a cross sectional analysis,” Drug and Alcohol Dependence, vol. 133, no. 1, pp. 254–261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Milhet and C. Raynaud-Maurupt, “Contemporary use of natural hallucinogens,” in Drugs and Culture Knowledge, Consumption and Policy, Sous la direction de Geoffrey Hunt, Maitena Milhet, and Henri Bergeron, Ashgate, 2011. View at Google Scholar
  42. A. Velter, “Enquêtes sur Internet: L'exemple de l'enquête Presse Gay,” Séminaire Enquêtes en population générale sur internet, IRESP/SFS, Espace Scipion, Paris, France, 2011, http://www.iresp.net/communication/colloques-et-seminaires.
  43. D. Frippiat and N. Marquis, “Les enquêtes par internet en sciences sociales: un état des lieux,” Population, vol. 65, no. 2, pp. 309–338, 2010. View at Publisher · View at Google Scholar
  44. S. Bava and S. F. Tapert, “Adolescent brain development and the risk for alcohol and other drug problems,” Neuropsychology Review, vol. 20, no. 4, pp. 398–413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Bryant and C. Treloar, “The gendered context of initiation to injecting drug use: evidence for women as active initiates,” Drug and Alcohol Review, vol. 26, no. 3, pp. 287–293, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. L. A. Novelli, S. G. Sherman, J. R. Havens, S. A. Strathdee, and M. Sapun, “Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users,” Drug and Alcohol Dependence, vol. 77, no. 3, pp. 303–309, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Wood, P. M. Spittal, T. Kerr et al., “Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention,” Canadian Journal of Public Health, vol. 94, no. 5, pp. 355–359, 2003. View at Google Scholar · View at Scopus
  48. W. Small, D. Fast, A. Krusi, E. Wood, and T. Kerr, “Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study,” Substance Abuse: Treatment, Prevention, and Policy, vol. 4, article 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Harocopos, L. A. Goldsamt, P. Kobrak, J. J. Jost, and M. C. Clatts, “New injectors and the social context of injection initiation,” International Journal of Drug Policy, vol. 20, no. 4, pp. 317–323, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Rhodes and A. Quirk, “Drug users' sexual relationships and the social organisation of risk: the sexual relationship as a site of risk management,” Social Science and Medicine, vol. 46, no. 2, pp. 157–169, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. A. M. Young, N. Larian, and J. R. Havens, “Gender differences in circumstances surrounding first injection experience of rural injection drug users in the United States,” Drug and Alcohol Dependence, vol. 134, no. 1, pp. 401–405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Bryant and C. Treloar, “Initiators: an examination of young injecting drug users who initiate others to injecting,” AIDS and Behavior, vol. 12, no. 6, pp. 885–890, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. N. K. Rotondi, C. Strike, G. Kolla et al., “Transition to injection drug use: the role of initiators,” AIDS and Behavior, vol. 18, no. 3, pp. 486–494, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Hunt, G. Stillwell, C. Taylor, and P. Griffiths, “Evaluation of a brief intervention to prevent initiation into injecting,” Drugs: Education, Prevention and Policy, vol. 5, no. 2, pp. 185–194, 1998. View at Google Scholar · View at Scopus
  55. C. Strike, M. Rotondi, G. Kolla et al., “Interrupting the social processes linked with initiation of injection drug use: results from a pilot study,” Drug and Alcohol Dependence, vol. 137, no. 1, pp. 48–54, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Roux, J. Le Gall, M. Debrus et al., “Innovative community-based educational face-to-face intervention to reduce HIV, HCV and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study,” Addiction, 2015. View at Publisher · View at Google Scholar
  57. R. Pates and D. Riley, Harm Reduction in Substance Use and High-Risk Behavior, Addiction Press, London, UK, 2012.
  58. L. Keijzer and E. Imbert, “Innover en RdR: le plafond de verre de la loi. Développer et faire évoluer les outils de réduction des risques. L'exemple de la seringue Noloss & un filtre pour usage de drogues: 20 ans d’évolution,” in Conférence de L'AFR 2013, December 2013.
  59. P. Bourgois and J. Bruneau, “Needle exchange, HIV infection, and the politics of science: confronting Canada's cocaine injection epidemic with participant observation,” Medical Anthropology: Cross Cultural Studies in Health and Illness, vol. 18, no. 4, pp. 325–350, 2000. View at Google Scholar · View at Scopus
  60. D. M. Patrick, M. W. Tyndall, P. G. A. Cornelisse et al., “Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection,” Canadian Medical Association Journal, vol. 165, no. 7, pp. 889–895, 2001. View at Google Scholar · View at Scopus
  61. M. W. Tyndall, S. Currie, P. Spittal et al., “Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic,” AIDS, vol. 17, no. 6, pp. 887–893, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. É. Roy, I. Richer, N. Arruda, J. Vandermeerschen, and J. Bruneau, “Patterns of cocaine and opioid co-use and polyroutes of administration among street-based cocaine users in Montréal, Canada,” International Journal of Drug Policy, vol. 24, no. 2, pp. 142–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Abelson, C. Treloar, J. Crawford, S. Kippax, I. Van Beek, and J. Howard, “Some characteristics of early-onset injection drug users prior to and at the time of their first injection,” Addiction, vol. 101, no. 4, pp. 548–555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. É. Roy, É. Nonn, and N. Haley, “Transition to injection drug use among street youth—a qualitative analysis,” Drug and Alcohol Dependence, vol. 94, no. 1–3, pp. 19–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. C. Taplin, S. Saddichha, K. Li, and M. R. Krausz, “Family history of alcohol and drug abuse, childhood trauma, and age of first drug injection,” Substance Use and Misuse, vol. 49, no. 10, pp. 1311–1316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. S. E. Hadland, D. Werb, T. Kerr et al., “Childhood sexual abuse and risk for initiating injection drug use: a prospective cohort study,” Preventive Medicine, vol. 55, no. 5, pp. 500–504, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Merkinaite, J. P. Grund, and A. Frimpong, “Young people and drugs: next generation of harm reduction,” International Journal of Drug Policy, vol. 21, no. 2, pp. 112–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. I. Obradovic, “Dix ans d'activité des ‘consultations jeunes consommateurs’,” Tendances, vol. 101, pp. 1–8, 2015, http://www.ofdt.fr/publications/collections/periodiques/lettre-tendances/dix-ans-dactivite-des-consultations-jeunes-consommateurs-tendances-101-avril-2015/. View at Google Scholar
  69. M. R. Polen, E. P. Whitlock, J. P. Wisdom, P. Nygren, and C. Bougatsos, “Screening in primary care settings for illicit drug use: staged systematic review for the United States Preventive Services Task Force,” in Evidence Syntheses, No.58.1, Agency for Healthcare Research and Quality, Rockville, Md, USA, 2008. View at Google Scholar
  70. C. D. Patnode, E. O'Connor, M. Rowland, B. U. Burda, L. A. Perdue, and E. P. Whitlock, “Primary care behavioral interventions to prevent or reduce illicit drug use and nonmedical pharmaceutical use in children and adolescents: a systematic evidence review for the U.S. Preventive Services Task Force,” Annals of Internal Medicine, vol. 160, no. 9, pp. 612–620, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Kreuter, S. Presser, and R. Tourangeau, “Social desirability bias in CATI, IVR, and web surveys: the effects of mode and question sensitivity,” Public Opinion Quarterly, vol. 72, no. 5, pp. 847–865, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Tourangeau and T. Yan, “Sensitive questions in surveys,” Psychological Bulletin, vol. 133, no. 5, pp. 859–883, 2007. View at Publisher · View at Google Scholar · View at Scopus